Precigen (PGEN) Equity Average (2013 - 2026)

Precigen (PGEN) has 14 years of Equity Average data on file, last reported at $20.6 million in Q1 2026.

• Equity Average for Q1 2026 came in at $20.6 million, up 68.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.6 million (up 68.27% YoY), and the FY2025 annual result was $29.7 million, down 62.15% from the prior year.
• Equity Average declined to $20.6 million in Q1 2026 per PGEN's latest filing, from $31.4 million in the prior quarter.
• Over five years, Equity Average peaked at $175.2 million in Q2 2023 and troughed at -$25.4 million in Q2 2025.
• A 5-year average of $77.9 million and a median of $70.1 million in 2024 frame the typical range for Equity Average.
• The sharpest annual moves came in 2023 and 2025: Equity Average soared 170.56% in 2023, then sank 136.26% in 2025.
• A 5-year view of Equity Average shows it stood at $134.4 million in 2022, then fell by 0.97% to $133.1 million in 2023, then plunged by 64.73% to $46.9 million in 2024, then sank by 33.13% to $31.4 million in 2025, then plunged by 34.46% to $20.6 million in 2026.
• Business Quant data shows PGEN's Equity Average at $20.6 million in Q1 2026, $31.4 million in Q4 2025, and $2.5 million in Q3 2025.